All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Incidence and Outcomes Associated With Early Heart Failure Pharmacotherapy in Patients with Ongoing Cardiogenic Shock

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F14%3A43908087" target="_blank" >RIV/00216208:11120/14:43908087 - isvavai.cz</a>

  • Result on the web

    <a href="http://dx.doi.org/10.1097/CCM.0b013e31829f6242" target="_blank" >http://dx.doi.org/10.1097/CCM.0b013e31829f6242</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1097/CCM.0b013e31829f6242" target="_blank" >10.1097/CCM.0b013e31829f6242</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Incidence and Outcomes Associated With Early Heart Failure Pharmacotherapy in Patients with Ongoing Cardiogenic Shock

  • Original language description

    Guidelines recommend beta-blockers and renin-angiotensin-aldosterone system blockers to improve long-term survival in hemodynamically stable myocardial infarction patients with a reduced left ventricular ejection fraction. The prevalence and outcomes associated with beta and renin-angiotensin-aldosterone system blocker therapy in patients with ongoing cardiogenic shock is unknown. In patients with cardiogenic shock lasting more than 24 hours enrolled in Tilarginine Acetate Injection in a Randomized International Study in Unstable Myocardial Infarction Patients With Cardiogenic Shock, we compared 30-day mortality in patients who received beta or renin-angiotensin-aldosterone system blockers within 24 hours of randomization with those who did not. The final study population included 240 patients. A total of 66 patients (27.5%) had either beta blocker or renin-angiotensin-aldosterone system blocker administered within the first 24 hours after the diagnosis of cardiogenic shock. Beta block

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FA - Cardiovascular diseases including cardio-surgery

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    N - Vyzkumna aktivita podporovana z neverejnych zdroju

Others

  • Publication year

    2014

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Critical Care Medicine

  • ISSN

    0090-3493

  • e-ISSN

  • Volume of the periodical

    42

  • Issue of the periodical within the volume

    2

  • Country of publishing house

    US - UNITED STATES

  • Number of pages

    8

  • Pages from-to

    281-288

  • UT code for WoS article

    000329863400023

  • EID of the result in the Scopus database